Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, August 15, 2023
[ Tue, Aug 15th 2023
] - WOPRAI
[ Tue, Aug 15th 2023
] - WOPRAI
Mon, August 14, 2023
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
Michael Petusky Upgraded (ANIK) to Buy and Held Target at $24 on, Aug 14th, 2023
Michael Petusky of Barrington Research, Upgraded "Anika Therapeutics, Inc." (ANIK) to Buy and Held Target at $24 on, Aug 14th, 2023.
Michael has made no other calls on ANIK in the last 4 months.
There is 1 other peer that has a rating on ANIK. Out of the 1 peers that are also analyzing ANIK, all agrees with Michael's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- George Sellers of "Stephens & Co." Maintained at Hold with Decreased Target to $23 on, Thursday, August 10th, 2023
